Polymed Biopharmaceuticals
Polymed creates novel PROTAC therapies for cancers and immunology HPB-143 (IRAK4) & HPB-092 (FLT3/IRAK4) clinic ready
2 employees · est. 2019 · Hangzhou, China
BiomX (NYSE: PHGE) is the older company (2015 vs 2019); BiomX (NYSE: PHGE) is the larger of the two.
Side-by-Side Comparison
| Metric | BiomX (NYSE: PHGE) | Polymed Biopharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2019 |
| Headquarters | ||
| Headquarters | Netanya, Israel | Hangzhou, China |
| Employees | ||
| Employees | 35 larger | 2 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | IPO | Series A |
| Total Funding | ||
| Total Funding | $169.30M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 9 | 1 |
| Services | ||
| Services | High-accuracy detection systems, AI-driven command and control systems, Drone-enabled technologies, Integrated security systems | Not tracked yet |
| Target Customers | ||
| Target Customers | Defense and Security Companies, National Security Agencies, Emergency Response Services, Infrastructure Security Managers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Microbiome Therapeutics, Microbiome Modulation, Phage Therapies, Drug Discovery, Preventive Medicine, Therapeutic Development, Scientific Research Collaboration, Innovation In Healthcare, Disease Prevention, Microbiome Imbalance, Microbiome Research | Biopharmaceuticals, PROTAC Therapies, Oncology, Autoimmune Diseases, Drug Development, Structural Biology, Small Molecule Inhibitors, Antibody Based Drugs, Cancer Research, Immunology, IND Submission, Strategic Partnerships, Targeted Therapies, Biotech |
| Website | ||
| Website | biomx.com | polymedbiopharma.com |
-logo.jpg){kind=logo}
About BiomX (NYSE: PHGE)
BiomX (NYSE: PHGE), founded in 2015 and headquartered in Israel, is an innovative player in the Biotechnology sector. The company operates within the broader fields of Health Care, Health and Wellness, and Pharmaceutical industries. Specializing in microbiome-based technologies, BiomX is positioni...
About Polymed Biopharmaceuticals
Polymed Biopharmaceuticals is a China-based biotechnology and pharmaceutical startup founded in 2018. The company specializes in developing novel protein degrader therapies for oncology and autoimmune diseases. Through the utilization of advanced technology platforms such as artificial intelligence...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at BiomX (NYSE: PHGE) and Polymed Biopharmaceuticals — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at BiomX (NYSE: PHGE) and Polymed Biopharmaceuti... — by email.
Frequently Asked Questions
Compare BiomX (NYSE: PHGE) with someone else
Start typing a company name or domain.